MARKETSEuropean Stocks Rise As Geopolitics Fall Away And Airlines SoarBy James SkinnerAug 15, 2017 11:25 AM EDT
STOCKSShire Surges On Baxalta Synergies and Strong Earnings MomentumBy James SkinnerAug 3, 2017 7:53 AM EDT
MARKETSEurope Stocks Slip as Economic Data and Politics Return to the ForeBy James SkinnerJun 23, 2017 12:09 PM EDT
STOCKSShire's Angioedema Success Could Be a Cure for a Bad Record in M&ABy James SkinnerMay 19, 2017 7:37 AM EDT
MARKETSEarnings and Economics Push European Benchmarks HigherBy James SkinnerMay 2, 2017 12:00 PM EDT
JIM CRAMERJim Cramer's 'Mad Money' Recap: Blame Tech, Oil and Retail for Today's LossesBy Scott RuttJan 12, 2015 8:32 PM EST
OPINIONCould AbbVie's Buyout of Shire Make It a New Dividend Aristocrat?By Ciaran ThorntonJul 18, 2014 3:58 PM EDT
VIDEOEuropean Markets Are Spooked by Ukraine and Gaza, but AbbVie Gets Shire DealBy Jonathan BraudeJul 18, 2014 7:26 AM EDT
JIM CRAMERCramer's 'Mad Money' Recap: Stroll in the JardenBy TheStreet.com StaffAug 18, 2005 7:19 PM EDT
OPINIONArbs Not Always to Blame When Acquiring Company's Stock FallsBy David BrailMay 29, 2000 12:39 PM EDT
STOCKSThursday's Company Report: SONS, TWSTY, FTE, WPI, KREM, TOM, WBy Kristen FrenchMay 25, 2000 7:46 PM EDT
STOCKSWatson Plans Schein Buy as Big Generic Drugmakers Look to Beef UpBy Dane HamiltonMay 25, 2000 6:06 PM EDT
